Project Description
PRoPosit is a Spanish medical company that has investigated new blood derivatives to be used at the clinical level in humans and veterinary fields. The PRoPosit PRP protocol is an a new Platelet-Rich Plasma (PRP) procedure developed by PRoPosit that allows the production of autologous Platelet-Rich Plasma of high purity and quality and a lower cost to be used in different medical specialist fields such as traumatology, dermatology, urology, aesthetic medicine, vascular surgery, etc.
PRoPosit contracted Qi to boost the technical and commercial development of its ‘Para-T’ device. The Para-T system is defined as a medical device to perform a direct, quick and permanent ABO group identification in a bag containing whole blood or red blood cells and/or in the catheter inserted in the vein of a patient, to identify the ABO group and to prevent incompatible transfusions between the transfusion bag and the recipient.
Qi carried out the business model, the preparation and defence of the EU grant and the related feasibility analysis during a period of around 2 years aimed at introducing the product in the market.
Project Details
Activities:
Working Areas:
- Business models for a circular economy
Client: PARA-T
Start Date: 2016
End Date: 2018
Central Office
Email: info@qiarrow.com
Phone: +34 910 337 799
Address: Av. Pablo VI, Nº 9, Puerta C, oficina C.
DP 28224, Pozuelo de Alarcón, MADRID.
Technology & I+D
Email: info@qiarrow.com
Address: Avenida Jean Claude Combaldieu s/n
Distrito Digital. Edificio 2, 03008 Alicante